Print Page     Close Window     

SEC Filings

10-Q
BIOTIME INC filed this Form 10-Q on 05/10/2018
Entire Document
 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  BIOTIME, INC.
   
Date: May 10, 2018 /s/ Michael D. West
  Michael D. West, Ph.D.
  Co-Chief Executive Officer

 

Date: May 10, 2018 /s/ Aditya Mohanty
  Aditya Mohanty
  Co-Chief Executive Officer

 

Date: May 10, 2018 /s/ Russell Skibsted
  Russell Skibsted
  Chief Financial Officer

 

36

© Copyright BioTime, Inc.